News

Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.
Srikakulam: In a serious breach of supply chain and internal controls, a group of eight individuals, including current and ...
In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9% with early and late discontinuation and nondiscontinuation, respectively.
Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...
A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...
Novo Nordisk stock climbs following the announcement of its plans to advance amycretin, a dual GLP-1/amylin agonist for ...
Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.
Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.
Novo Nordisk is progressing both subcutaneous and oral versions of amycretin into Phase III trials for patients with obesity and who are overweight. Following a positive end-of-Phase II meeting, Novo ...
I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did she have weight loss surgery?” “I hope he’s not sick.” What seems to be ...